Predictors of Pseudomonas and methicillin‐resistant Staphylococcus aureus in hospitalized patients with healthcare‐associated pneumonia

Patients with healthcare‐associated pneumonia (HCAP) are at high risk of infection with multidrug‐resistant (MDR) pathogens. Factors discriminating infection with MDR Gram‐negative (MDR‐GN) organism from infection with methicillin‐resistant Staphylococcus aureus (MRSA) are not well understood and patients are often treated for both organisms. This study was performed to determine risk factors predicting pneumonia due to Pseudomonas versus MRSA.

[1]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[2]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[3]  Marin H Kollef,et al.  Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. , 2005, Chest.

[4]  古谷 良輔,et al.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.

[5]  M. Kollef,et al.  Health Care-Associated Pneumonia and Community-Acquired Pneumonia: a Single-Center Experience , 2007, Antimicrobial Agents and Chemotherapy.

[6]  J. Dorca,et al.  Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. , 2007, Archives of internal medicine.

[7]  M. Niederman,et al.  Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  Marin H Kollef,et al.  Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. , 2008, Archives of internal medicine.

[9]  M. Niederman,et al.  Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia , 2009, Current opinion in infectious diseases.

[10]  Y. Hasegawa,et al.  Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. , 2009, Chest.

[11]  Ronald N. Jones.  Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  A. Akram,et al.  Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  J. Pépin,et al.  Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia. , 2011, The Journal of antimicrobial chemotherapy.

[14]  A. Anzueto,et al.  Guideline-concordant therapy and outcomes in healthcare-associated pneumonia , 2011, European Respiratory Journal.

[15]  M. Kollef,et al.  Health Care-Associated Pneumonia (HCAP): Empiric Antibiotics Targeting Methicillin-Resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa Predict Optimal Outcome , 2011, Medicine.

[16]  S. Corrao,et al.  Clinical impact of broad-spectrum empirical antibiotic therapy in patients with healthcare-associated pneumonia: a multicenter interventional study , 2012, Internal and Emergency Medicine.

[17]  M. Kollef,et al.  Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  E. Y. Kim,et al.  Poor prediction of potentially drug-resistant pathogens using current criteria of health care-associated pneumonia. , 2012, Respiratory medicine.

[19]  H. Vikram,et al.  Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia. , 2012, Respiratory medicine.

[20]  V. Fan,et al.  Guideline-Based Antibiotics and Mortality in Healthcare-Associated Pneumonia , 2012, Journal of General Internal Medicine.

[21]  M. Kollef,et al.  A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia , 2013, BMC Infectious Diseases.

[22]  H. Saka,et al.  Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. , 2013, American journal of respiratory and critical care medicine.

[23]  G. Waterer,et al.  Healthcare‐associated pneumonia: A US disease or relevant to the Asia Pacific, too? , 2013, Respirology.

[24]  T. Kishaba,et al.  A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP) , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[25]  H. Matsui,et al.  Reevaluation of the Japanese guideline for healthcare-associated pneumonia in a medium-sized community hospital in Japan , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[26]  E. Y. Kim,et al.  Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia , 2013, BMC Infectious Diseases.

[27]  Byeong-Ho Jeong,et al.  Performances of prognostic scoring systems in patients with healthcare-associated pneumonia. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  A. Shorr,et al.  Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009. , 2013, Journal of hospital medicine.

[29]  J. Rello,et al.  Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case–control study , 2013, Thorax.

[30]  M. Metersky,et al.  Is the present definition of health care-associated pneumonia the best way to define risk of infection with antibiotic-resistant pathogens? , 2013, Infectious disease clinics of North America.

[31]  Y. Kang,et al.  Validation of a scoring tool to predict drug-resistant pathogens in hospitalised pneumonia patients. , 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[32]  M. Niederman,et al.  A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  S. Ewig,et al.  Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  S. Bouallègue,et al.  A New Method , 2021, Black Power and the American Myth.